FDA Approved: FLUVASTATIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Fluvastatin from Teva Pharmaceuticals USA, Inc. to update the product labeling (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Fluvastatin (fluvastatin)

Snippet

SUPPL AP for FLUVASTATIN (FLUVASTATIN)